Dr Lal Pathlabs Ltd

Dr Lal Pathlabs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Lal Pathlabs Ltd

₹ 2,911 4.41%
25 Apr - close price
lalpathlabs.com BSE: 539524 NSE: LALPATHLAB
About

Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates. [1]

Key Points

About[1]
It is the largest diagnostics chain with a PAN India presence The company has 70+ yrs of experience in the field of diagnostics. The company has serviced 122 Mn+ patients
in the last 5 years.

Website BSE NSE
  • Market Cap ₹ 24,335 Cr.
  • Current Price ₹ 2,911
  • High / Low ₹ 3,654 / 2,201
  • Stock P/E 48.9
  • Book Value ₹ 255
  • Dividend Yield 0.82 %
  • ROCE 29.8 %
  • ROE 24.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 32.2%

Cons

  • Stock is trading at 11.4 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE 500 BSE Allcap BSE SmallCap Select Index BSE 250 SmallCap Index BSE 400 MidSmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
416 440 467 429 431 480 532 476 521 534 584 569 577
311 331 337 325 315 344 369 346 383 379 399 418 418
Operating Profit 105 110 130 105 116 136 163 130 138 156 184 151 159
OPM % 25% 25% 28% 24% 27% 28% 31% 27% 26% 29% 32% 27% 28%
13 19 8 9 12 15 14 15 16 29 22 31 25
Interest 11 8 10 8 8 7 7 6 6 6 5 5 5
Depreciation 22 19 21 21 21 18 19 19 35 18 18 34 35
Profit before tax 85 102 106 84 98 125 151 120 113 161 183 144 145
Tax % 23% 22% 26% 26% 27% 25% 25% 26% 29% 24% 26% 27% -2%
65 80 79 63 71 94 113 88 81 123 135 105 148
EPS in Rs 7.83 9.56 9.43 7.51 8.56 11.22 13.54 10.58 9.68 14.72 16.18 12.61 17.75
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
541 637 765 882 1,024 1,165 1,274 1,491 1,879 1,769 1,967 2,352
406 486 562 651 768 882 946 1,083 1,366 1,308 1,408 1,686
Operating Profit 135 151 204 230 256 283 328 408 512 461 559 666
OPM % 25% 24% 27% 26% 25% 24% 26% 27% 27% 26% 28% 28%
8 17 20 28 31 46 58 51 53 47 60 112
Interest 0 0 0 1 1 1 15 15 29 34 27 22
Depreciation 31 32 32 26 31 36 68 70 76 82 77 134
Profit before tax 111 135 192 231 256 292 303 374 461 391 516 621
Tax % 34% 32% 34% 34% 34% 33% 26% 25% 25% 25% 26% 20%
74 92 126 152 168 195 223 280 345 292 384 497
EPS in Rs 137.77 16.80 15.21 18.36 20.19 23.45 26.78 33.61 41.42 35.07 46.04 59.49
Dividend Payout % 8% 9% 16% 16% 22% 26% 45% 60% 29% 17% 39% 40%
Compounded Sales Growth
10 Years: 14%
5 Years: 13%
3 Years: 8%
TTM: 20%
Compounded Profit Growth
10 Years: 18%
5 Years: 17%
3 Years: 13%
TTM: 29%
Stock Price CAGR
10 Years: %
5 Years: 13%
3 Years: 1%
1 Year: 22%
Return on Equity
10 Years: 24%
5 Years: 23%
3 Years: 22%
Last Year: 25%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 54 55 83 83 83 83 83 83 83 83 83 84
Reserves 135 238 397 503 693 847 933 1,134 1,389 1,606 1,816 2,051
27 27 -0 -0 -0 -0 -0 38 385 281 136 151
116 130 112 90 119 136 302 318 354 350 380 336
Total Liabilities 331 449 592 676 896 1,067 1,318 1,573 2,211 2,320 2,415 2,621
114 119 130 121 173 173 297 300 371 361 343 1,051
CWIP 0 1 4 17 9 3 11 9 14 5 6 4
Investments 20 49 74 134 174 214 253 171 1,062 1,213 1,143 416
197 280 384 404 540 677 757 1,093 764 740 924 1,151
Total Assets 331 449 592 676 896 1,067 1,318 1,573 2,211 2,320 2,415 2,621

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
96 94 142 167 189 208 272 373 426 428 478
-86 -86 -148 -134 -166 -93 -19 -195 -449 -288 32
-10 1 1 -32 13 -54 -187 -136 141 -270 -404
Net Cash Flow 0 9 -5 1 36 61 65 42 118 -131 106

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 16 17 17 17 14 17 14 16 13 13 14 16
Inventory Days 37 31 33 44 40 70 38 32 22 26 26
Days Payable 89 88 97 104 110 143 132 101 131 156 155
Cash Conversion Cycle 16 -35 -41 -47 -45 -54 -59 -79 -55 -96 -116 -113
Working Capital Days -28 -10 28 15 18 1 -16 -16 -15 -21 -22 27
ROCE % 61% 51% 48% 44% 38% 34% 33% 34% 31% 22% 27% 30%

Shareholding Pattern

Numbers in percentages

6 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
55.05% 55.04% 55.04% 55.03% 55.01% 54.61% 54.60% 54.60% 54.60% 53.92% 53.91% 53.91%
22.37% 23.26% 25.80% 24.89% 23.27% 24.35% 25.36% 26.15% 25.43% 26.82% 26.82% 23.90%
6.52% 6.27% 6.20% 6.56% 8.34% 8.85% 9.27% 9.40% 12.42% 12.60% 12.88% 15.79%
0.00% 0.00% 0.00% 0.00% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29% 0.29%
15.46% 14.84% 12.38% 13.01% 12.65% 11.48% 10.12% 9.24% 6.95% 6.02% 5.82% 5.84%
0.60% 0.58% 0.56% 0.51% 0.44% 0.41% 0.37% 0.32% 0.30% 0.33% 0.28% 0.27%
No. of Shareholders 1,84,5081,71,6021,79,6361,80,1631,74,4441,60,6791,49,9011,46,7411,31,1891,16,6061,16,2361,15,699

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls